Daniel Baumann
Impact in
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Metal complexes synthesis and properties 2
-
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 2
- Co-authors
- Rienk Offringa (7 shared papers)Petra Högger (2 shared papers)Claus Bachert (2 shared papers)Oliver Strohmeier (2 shared papers)Fabian Stumpf (2 shared papers)Daniel Mark (2 shared papers)Roland Zengerle (2 shared papers)Frank Schwemmer (2 shared papers)
In The Last Decade
Daniel Baumann
23 papers receiving 824 citations
Peers
Comparison fields: 5 of 111
- Oncology 194
- Biological Psychiatry 18
- Immunology 117
- Pharmaceutical Science 29
- Cancer Research 60
Countries citing papers authored by Daniel Baumann
This map shows the geographic impact of Daniel Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Baumann more than expected).
Fields of papers citing papers by Daniel Baumann
This network shows the impact of papers produced by Daniel Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Baumann. The network helps show where Daniel Baumann may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Baumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 123 | |
| 2 | [New drugs. 3]. | 1970 | 85 |
| 3 | [New drugs. 8]. | 1972 | 73 |
| 4 | [New drugs. 5]. | 1971 | 72 |
| 5 | [New drugs. 6]. | 1971 | 69 |
| 6 | [New drugs. 9]. | 1973 | 68 |
| 7 | 2023 | 64 | |
| 8 | 2020 | 60 | |
| 9 | 2013 | 49 | |
| 10 | 2021 | 39 | |
| 11 | 2009 | 33 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 19 | |
| 14 | 2018 | 16 | |
| 15 | A double-antibody sandwich ELISA for the detection of Entamoeba histolytica antigen in stool samples of humans. | 1987 | 15 |
| 16 | 1975 | 13 | |
| 17 | 2020 | 12 | |
| 18 | 1976 | 9 | |
| 19 | 2011 | 8 | |
| 20 | 2015 | 3 |
About Daniel Baumann
Daniel Baumann is a scholar working on Oncology, Immunology, Electronic, Optical and Magnetic Materials, Organic Chemistry and Infectious Diseases, having authored 26 papers that have together received 868 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Organometallic Complex Synthesis and Catalysis (4 papers), Immunotherapy and Immune Responses (3 papers), Magnetism in coordination complexes (3 papers), CAR-T cell therapy research (2 papers), Metal complexes synthesis and properties (2 papers), Immune cells in cancer (2 papers) and Biosensors and Analytical Detection (2 papers). The work is most often cited by research in Oncology (194 citations), Biological Psychiatry (18 citations), Immunology (117 citations), Pharmaceutical Science (29 citations) and Cancer Research (60 citations). Daniel Baumann has collaborated with scholars based in Germany, Belgium and China. Frequent co-authors include Rienk Offringa, Petra Högger, Claus Bachert, Oliver Strohmeier, Fabian Stumpf, Daniel Mark, Roland Zengerle, Frank Schwemmer, Felix von Stetten and Tobias Hutzenlaub. Their work appears in journals such as Scientific Reports, Journal for ImmunoTherapy of Cancer, Cell Stress, European Journal of Pharmaceutics and Biopharmaceutics and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.